Literature DB >> 7768248

Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency.

R W van Olden1, J J van Meyel, P G Gerlag.   

Abstract

Ten haemodialysis (HD) patients with a median residual creatinine clearance (CLCR) of 1.9 ml.min-1 x 1.73 m-2 (range 0.6-5.3) were treated with oral furosemide (F) 2.0 g. Overall-efficiency (O-E, daily sodium excretion/total urinary F) and total-efficiency (delta-E, increase in daily sodium excretion/total urinary F) were measured on the last 24 hours of each interdialysis interval. In addition, O-E was measured during the complete interdialysis interval in 10 HD patients with a median CLCR of 5.6 ml.min-1 x 1.73 m-2 (range 0.7-6.8) treated for 1 year with a fixed oral dose of F between 250-1000 mg (median 625 mg). In the short study the median O-E was 10.6 mmol.mg-1 (range 1.9-22.0) and delta-E 6.2 mmol.mg-1 (range 1.3-11.2). The fractional excretion of sodium FENa was significantly increased from 9.6% (range 4.1-22.9) to 27% (range 14.6-56.2) during F treatment. A positive correlation was found between the basal FENa and delta-E. In the long-term study median O-E was 6.4 mmol.mg-1. O-E and FENa showed no change over time although median RCC decreased from 5.6 to 1.9 ml.min-1 x 1.73 m-2 and median F excretion from 11.8 to 7.5 mg per day. It can be concluded that diuretic efficiency in haemodialysis patients is dependent on FENa and the state of hydration during the interdialysis interval.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768248     DOI: 10.1007/BF00193698

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  22 in total

1.  Acute and long-term effects of therapy with high-dose furosemide in chronic hemodialysis patients.

Authors:  R W van Olden; J J van Meyel; P G Gerlag
Journal:  Am J Nephrol       Date:  1992       Impact factor: 3.754

2.  The validity of the sigmoid Emax model and efficiency concept in diuretic studies.

Authors:  G Alván; M Hammarlund-Udenaes; B Odlind
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

3.  Mechanism of impaired natriuretic response to furosemide during prolonged therapy.

Authors:  N R Loon; C S Wilcox; R J Unwin
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

Review 4.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

5.  Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers.

Authors:  J J van Meyel; P Smits; F G Russel; P G Gerlag; Y Tan; F W Gribnau
Journal:  Clin Pharmacol Ther       Date:  1992-04       Impact factor: 6.875

Review 6.  Clinical pharmacology of loop diuretics.

Authors:  D C Brater
Journal:  Drugs       Date:  1991       Impact factor: 9.546

7.  Specimen handling and high-performance liquid chromatographic determination of furosemide.

Authors:  A L Kerremans; Y Tan; C A Van Ginneken; F W Gribnau
Journal:  J Chromatogr       Date:  1982-04-16

8.  Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling.

Authors:  M M Hammarlund; B Odlind; L K Paalzow
Journal:  J Pharmacol Exp Ther       Date:  1985-05       Impact factor: 4.030

9.  Comparison of loop diuretics in patients with chronic renal insufficiency.

Authors:  J R Voelker; D Cartwright-Brown; S Anderson; J Leinfelder; D A Sica; J P Kokko; D C Brater
Journal:  Kidney Int       Date:  1987-10       Impact factor: 10.612

10.  Diuretic effect and diuretic efficiency after intravenous dosage of frusemide.

Authors:  G Alván; L Helleday; A Lindholm; E Sanz; T Villén
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

View more
  4 in total

Review 1.  Diuretics in pediatrics : current knowledge and future prospects.

Authors:  Maria M J van der Vorst; Joana E Kist; Albert J van der Heijden; Jacobus Burggraaf
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 2.  Diuretic use in renal disease.

Authors:  Domenic A Sica
Journal:  Nat Rev Nephrol       Date:  2011-12-20       Impact factor: 28.314

3.  Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis.

Authors:  Helton P Lemes; Salustiano Araujo; Daniella Nascimento; Danny Cunha; Cesar Garcia; Vinicius Queiroz; Sebastião R Ferreira-Filho
Journal:  Clin Exp Nephrol       Date:  2011-03-18       Impact factor: 2.801

Review 4.  The importance of residual renal function in chronic dialysed patients.

Authors:  Daniela Rădulescu; Dumitru Ferechide
Journal:  J Med Life       Date:  2009 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.